What's Hot

    Australian authorities are searching for a missing radioactive capsule

    January 28, 2023

    Feds say Florida nursing schools sold 7,600 fake diplomas

    January 28, 2023

    German-Australian hydrogen supply chain investment of $90 million

    January 28, 2023
    Facebook Twitter Instagram
    Trending
    • Australian authorities are searching for a missing radioactive capsule
    • Feds say Florida nursing schools sold 7,600 fake diplomas
    • German-Australian hydrogen supply chain investment of $90 million
    • Pakistan economy in danger of collapsing due to loan defaults
    • Global growth will slow to 1.9 percent in 2023, warn UN economists
    • Modi-Sisi sign MoUs to boost Indian-Egyptian trade to $12 billion
    • OPEC fund loans $120 million to Panama to tackle climate change
    • Ship carrying 22 sinks off Jeju, 14 rescued, 9 unconscious
    • Home
    • Contact Us
    South Africa GazetteSouth Africa Gazette
    Saturday, January 28
    • Automotive
    • Business
    • Entertainment
    • Health
    • Luxury
    • Lifestyle
    • News
    • Sports
    • Technology
    • Travel
    South Africa GazetteSouth Africa Gazette
    Home » Korea to receive 40 million COVID vaccines from Moderna

    Korea to receive 40 million COVID vaccines from Moderna

    March 4, 2021
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Moderna Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, confirmed that the Company has entered into a supply agreement with the government of the Republic of Korea to provide 40 million doses of the Moderna COVID-19 Vaccine to support the government’s aim of providing vaccines to the public as soon as possible. Under the terms of the proposed agreement, deliveries would begin in May 2021.

    Korea to receive 40 million COVID vaccines from Moderna
    Moderna is advancing messenger RNA (mRNA) science to create a new class of transformative medicines for patients. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that can have a therapeutic or preventive benefit and have the potential to address a broad spectrum of diseases. 

    The company’s platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, providing Moderna the capability to pursue in parallel a robust pipeline of new development candidates. Moderna is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune and inflammatory diseases, independently and with strategic collaborators.

    Headquartered in Cambridge, Mass., Moderna currently has strategic alliances for development programs with AstraZeneca PLC and Merck & Co., Inc., as well as the Defense Advanced Research Projects Agency (DARPA), an agency of the U.S. Department of Defense, and BARDA. Moderna has been named a top biopharmaceutical employer by Science for the past six years. To learn more, visit their website.

    Keep Reading

    Feds say Florida nursing schools sold 7,600 fake diplomas

    60,000 Coronavirus deaths confirmed by China as WHO investigates

    Travelers should wear masks as a new COVID variant spreads – WHO

    World in a better place after four years of pandemic – WHO

    UK-based firm reports 9,000 daily deaths from COVID in China

    Death of a Korean man caused by brain-eating Amoeba – Naegleia Fowleri

    Latest News

    Australian authorities are searching for a missing radioactive capsule

    January 28, 2023

    Feds say Florida nursing schools sold 7,600 fake diplomas

    January 28, 2023

    German-Australian hydrogen supply chain investment of $90 million

    January 28, 2023

    Pakistan economy in danger of collapsing due to loan defaults

    January 27, 2023

    Global growth will slow to 1.9 percent in 2023, warn UN economists

    January 26, 2023

    Modi-Sisi sign MoUs to boost Indian-Egyptian trade to $12 billion

    January 26, 2023

    OPEC fund loans $120 million to Panama to tackle climate change

    January 26, 2023
    © 2022 South Africa Gazette | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.